3 IgA Nephropathy Clinical Trials in Aurora, CO (2026)

Q: How do I join a clinical trial in Aurora?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you.

Recruiting IgA Nephropathy Studies in Aurora

NCT04557462Recruiting

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

The purpose of this study is to evaluate the long-term safety and tolerability, of open label iptacopan in primary IgA nephropathy participants who have completed either the CLNP023X2203 or CLNP023A23...

Aurora, COPHASE3540 participantsNovartis Pharmaceuticals

View Study Details

NCT07024563Recruiting

Study of Ravulizumab in Pediatric Participants With Primary IgAN

The primary objectives of this study are to characterize ravulizumab pharmacokinetics (PK) and pharmacodynamics (PD), and to evaluate safety and efficacy following ravulizumab IV dosing in pediatric p...

Aurora, COPHASE336 participantsAlexion Pharmaceuticals, Inc.

View Study Details

NCT06994845Recruiting

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

The study is an open-label, single arm, multicenter, Phase III study to determine proteinuria reduction, pharmacokinetics (PK), safety and tolerability (including CV surveillance) of iptacopan in prim...

Aurora, COPHASE331 participantsNovartis Pharmaceuticals

View Study Details

About IgA Nephropathy Clinical Trials in Aurora

IgA nephropathy is the most common form of glomerulonephritis worldwide, caused by deposits of immunoglobulin A in the kidneys. It can lead to kidney inflammation and progressive kidney damage. Treatment includes blood pressure management, immunosuppression, and newer targeted therapies.

There are currently 3 iga nephropathy clinical trials recruiting participants in Aurora, CO. These studies are seeking a combined 607 participants. Research is being sponsored by Novartis Pharmaceuticals, Alexion Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

IgA Nephropathy Clinical Trials in Aurora — FAQ

Are there iga nephropathy clinical trials in Aurora?

Yes, there are 3 iga nephropathy clinical trials currently recruiting in Aurora, CO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Aurora?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you about next steps.

Are clinical trials in Aurora free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Aurora studies also compensate for your time and travel.

What iga nephropathy treatments are being tested?

The 3 active trials in Aurora are testing new therapies including novel drugs, biologics, and treatment approaches for iga nephropathy.

Data updated October 5, 2026 from ClinicalTrials.gov